Chronokines

Delivering Breakthrough Medicines for Rare Hematologic Diseases and Cancers

Emilie Branch; Frank D. Lee

Pharma's Almanac

Chronokines

Solving Unmet Clinical Needs by Harnessing the Science of Aging

Emilie Branch; Elizabeth Jeffords

Pharma's Almanac

Cancer Therapies

Computational Discoveries for Clinical Development of Novel Cancer Therapies

David Alvaro, Ph.D.; Anat Cohen-Dayag, Ph.D.

Pharma's Almanac

In Conversation

Novel Off-The-Shelf Targeted Cell Therapies

Gary Lord; Dago Caceres; David Alvaro, Ph.D.; Sonny Hsiao, Ph.D.

Dow Chemicals

In Conversation

NantKwest — Harnessing Natural Killer Cells to Treat Cancer

Emilie Branch; Gary Lord; Dago Caceres; Patrick Soon-Shiong, M.D.

Pharma's Almanac

In Conversation

Putting Pressure on Quality Research, Drug Development, and Cannabis (CBD) Products

Gary Lord; Dago Caceres; David Alvaro, Ph.D.; Richard T. Schumacher

Dow Chemicals

In Conversation

Behind the Scenes of International Pharmaceutical Business Success: A Conversation with Horst Wallrabe

Haig Armaghanian; Horst Wallrabe

Haig Barrett

In Conversation

Mergers & Acquisitions: Combining Market Segments

Guy Tiene; Gary Lord; Dago Caceres

Nice Insight

Operational Excellence in Outsourced Fill-Finish Services

Guy Tiene; Oskar Gold

Nice Insight

Capsugel’s Transformation: Q&A with Guido Driesen

Nigel Walker; Guido Driesen

Nice Insight

The Importance of Flexibility: Competitive Solutions in an Era of Innovation

Guy Tiene; Uwe Harbauer

Nice Insight

Inline

Innovating Equipment: Inline Buffer Dilution Technology

Guy Tiene; Kimo Sanderson

Nice Insight